Harsh Patel

532 total citations · 1 hit paper
21 papers, 345 citations indexed

About

Harsh Patel is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Harsh Patel has authored 21 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Surgery. Recurrent topics in Harsh Patel's work include Drug Transport and Resistance Mechanisms (3 papers), Epigenetics and DNA Methylation (2 papers) and RNA Interference and Gene Delivery (2 papers). Harsh Patel is often cited by papers focused on Drug Transport and Resistance Mechanisms (3 papers), Epigenetics and DNA Methylation (2 papers) and RNA Interference and Gene Delivery (2 papers). Harsh Patel collaborates with scholars based in United States, China and India. Harsh Patel's co-authors include Zhe‐Sheng Chen, John M. Higgins, Hasmukh Patel, Yumin Wang, Jinhua Wang, Hongquan Wang, Jichao Chen, Yan Wang, Letao Bo and Zhuo‐Xun Wu and has published in prestigious journals such as SHILAP Revista de lepidopterología, The American Journal of Sports Medicine and The American Journal of Gastroenterology.

In The Last Decade

Harsh Patel

17 papers receiving 341 citations

Hit Papers

Epigenetic modification of m6A regulator proteins in cancer 2023 2026 2024 2025 2023 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harsh Patel United States 9 157 112 70 48 45 21 345
Cristian Virgil Lungulescu Romania 11 163 1.0× 142 1.3× 111 1.6× 59 1.2× 24 0.5× 43 406
Han-Lin Hsu Taiwan 12 105 0.7× 87 0.8× 85 1.2× 105 2.2× 40 0.9× 19 352
Amr Elkholy United States 10 156 1.0× 57 0.5× 72 1.0× 57 1.2× 21 0.5× 23 272
Xiaoli Xu China 12 75 0.5× 111 1.0× 59 0.8× 81 1.7× 43 1.0× 30 319
Parham Khosravi‐Shahi Spain 10 68 0.4× 124 1.1× 66 0.9× 83 1.7× 24 0.5× 22 319
Ziwei Zhou China 9 157 1.0× 68 0.6× 56 0.8× 133 2.8× 72 1.6× 18 377
Xiangming Yan China 11 209 1.3× 89 0.8× 94 1.3× 58 1.2× 30 0.7× 21 356
Shiyong Lin China 9 79 0.5× 75 0.7× 48 0.7× 54 1.1× 72 1.6× 14 316
Bhawna Mahajan India 12 123 0.8× 48 0.4× 44 0.6× 49 1.0× 66 1.5× 46 346
Yiwen Sang China 10 131 0.8× 67 0.6× 72 1.0× 31 0.6× 41 0.9× 19 278

Countries citing papers authored by Harsh Patel

Since Specialization
Citations

This map shows the geographic impact of Harsh Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harsh Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harsh Patel more than expected).

Fields of papers citing papers by Harsh Patel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harsh Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harsh Patel. The network helps show where Harsh Patel may publish in the future.

Co-authorship network of co-authors of Harsh Patel

This figure shows the co-authorship network connecting the top 25 collaborators of Harsh Patel. A scholar is included among the top collaborators of Harsh Patel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harsh Patel. Harsh Patel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Bohan, Xiang Chen, Letao Bo, et al.. (2025). Overcoming multidrug resistance in cancer cells targeting ABC transporter ABCB1 with tyrosine kinase inhibitor: Olverembatinib. Experimental Cell Research. 455(1). 114851–114851.
2.
Tian, Qin, Jinxiang Wang, Qiji Li, et al.. (2025). Branched‐Chain α Keto‐Acid Dehydrogenase Kinase‐Mediated AKT Phosphorylation Promotes RCC Tumorigenesis and Drug Resistance. Advanced Science. 12(40). e11081–e11081.
3.
Zhang, Chaolei, Yifeng Jin, Harsh Patel, et al.. (2025). Phase separation of EEF1E1 promotes tumor stemness via PTEN/AKT-mediated DNA repair in hepatocellular carcinoma. Cancer Letters. 613. 217508–217508. 8 indexed citations
4.
Patel, Harsh, Jiaxin Li, Letao Bo, et al.. (2024). Nanotechnology-based delivery systems to overcome drug resistance in cancer. SHILAP Revista de lepidopterología. 4(1). 5–30. 13 indexed citations
5.
Sun, Haidong, et al.. (2024). Therapeutic evolution in HR+/HER2- breast cancer: from targeted therapy to endocrine therapy. Frontiers in Pharmacology. 15. 1340764–1340764. 17 indexed citations
6.
Patel, Harsh, et al.. (2023). Dostarlimab in the treatment of mismatch repair deficient recurrent or advanced endometrial cancer. PubMed. 2(3). 135–141. 2 indexed citations
7.
Wang, Yumin, Yan Wang, Harsh Patel, et al.. (2023). Epigenetic modification of m6A regulator proteins in cancer. Molecular Cancer. 22(1). 102–102. 104 indexed citations breakdown →
8.
Patel, Harsh, et al.. (2023). Study of dry eye syndrome: Focus on causative factors, treatment modalities, quality of life, and preservatives used in eye drops. Indian Journal of Ophthalmology. 71(4). 1587–1592. 2 indexed citations
9.
Patel, Harsh, et al.. (2023). S4241 Perforated Gastric Ulcer Complicated by Peritonitis and Pelvic Abscesses in a Patient With Diabetic Ketoacidosis. The American Journal of Gastroenterology. 118(10S). S2681–S2682.
10.
Saraswat, Aishwarya, et al.. (2022). Palmitoyl Carnitine-Anchored Nanoliposomes for Neovasculature-Specific Delivery of Gemcitabine Elaidate to Treat Pancreatic Cancer. Cancers. 15(1). 182–182. 14 indexed citations
11.
Berlinberg, Elyse J., Hasani W. Swindell, Harsh Patel, et al.. (2022). The Epidemiology of Platelet-Rich Plasma Injections From 2010 to 2020 in a Large US Commercial Insurance Claims Database: A Recent Update. Journal of the American Academy of Orthopaedic Surgeons. 31(3). e135–e147. 7 indexed citations
12.
Forsythe, Brian, Elyse J. Berlinberg, Avinaash Korrapati, et al.. (2022). No Difference in Clinical Outcomes for Arthroscopic Suprapectoral Versus Open Subpectoral Biceps Tenodesis at Midterm Follow-up: A Randomized Prospective Analysis. The American Journal of Sports Medicine. 50(6). 1486–1494. 12 indexed citations
13.
Patel, Harsh, Zhuo‐Xun Wu, Yanglu Chen, Letao Bo, & Zhe‐Sheng Chen. (2021). Drug resistance: from bacteria to cancer. Molecular Biomedicine. 2(1). 26 indexed citations
14.
Wu, Zhuo‐Xun, Yuqi Yang, Leli Zeng, et al.. (2021). Establishment and Characterization of an Irinotecan-Resistant Human Colon Cancer Cell Line. Frontiers in Oncology. 10. 624954–624954. 19 indexed citations
15.
Patel, Harsh, Dhivya Srinivasa, Oksana Volod, Eric D. Wang, & Esther A. Kim. (2021). Rotational Thromboelastometry Derivative Fibrinogen–Platelet Ratio Predicts Thrombosis in Microsurgery. Journal of Reconstructive Microsurgery. 37(9). 774–782. 4 indexed citations
16.
Patel, Harsh, et al.. (2021). Rare Occurrence of Hyperkalemia Following Remdesivir: A Case Series. 2(5). 4–6. 1 indexed citations
17.
Patel, Harsh, et al.. (2018). Complete Genome Sequences of Six BI Cluster Streptomyces Bacteriophages, HotFries, Moozy, Rainydai, RavenPuff, Scap1, and SenditCS. Microbiology Resource Announcements. 7(12). 3 indexed citations
18.
Patel, Harsh, Hasmukh Patel, & John M. Higgins. (2015). Modulation of red blood cell population dynamics is a fundamental homeostatic response to disease. American Journal of Hematology. 90(5). 422–428. 80 indexed citations
19.
Sun, Xuanhao, et al.. (2014). A microfluidic platform for profiling biomechanical properties of bacteria. Lab on a Chip. 14(14). 2491–2498. 27 indexed citations
20.
Patel, Harsh, et al.. (2009). Thrombotic Thrombocytopenic Purpura: The Masquerader. Southern Medical Journal. 102(5). 504–509. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026